Emodin Prolongs Recipient Survival Time After Orthotopic Liver Transplantation in Rats by Polarizing the Th1/Th2 Paradigm to Th2

Anatomical Record

Volumn 294, Issue 3, 2011, Pages 445-452

  Tong, Hongfei ^a   Chen, Kangjie ^a   Chen, Hui ^a   Wu, Huayong ^a   Lin, Haiduo ^a   Ni, Zhonglin ^a   Lin, Shengzhang ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Emodin; Liver transplantation; Survival time; Th1 Th2

Indexed keywords

EMODIN; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL TIME; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; EMODIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LIVER; LIVER TRANSPLANTATION; MALE; MOLECULAR STRUCTURE; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED BN; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TH1 CELLS; TH2 CELLS;

RATTUS;

EID: 79951759176     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21352     Document Type: Article

References (29)

1. Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, Nikbin B. 2005. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transp Proc 37: 2985-2987.
2. Chen Y, Chen J, Liu Z, Liang S, Luan X, Long F, Peng Y, Yan L, Gong J. 2008. Relationship between TH1/TH2 cytokines and immune tolerance in liver transplantation in rats. Transp Proc 40: 2691-2695.
3. Chou TH, Liang CH. 2009. The molecular effects of aloe-emodin (AE)/liposome-AE on human nonmelanoma skin cancer cells and skin permeation. Chem Res Toxicol 22: 2017-2028.
4. Demetrius AJ, Batts KP, Dhillon AP, Ferrell L, Fung J, Geller SA, Hart J, Hayry P, Hofmann WJ, Hubscher S, Kemnitz J, Koukoulis G, Lee RG, Lewin KJ, Ludwig J, Markin RS, Petrovic LM, Phillips MJ, Portmann B, Rakela J, Ramdhawa P, Reinholt FP, Reyne's M, Robert M, Schlitt H, Solez K, Snover D, Taskinen E, Thung SN, Tillery GW, Wiesner RH, Derek Wight DG, Williams JW, Yamabe H. 1997. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25: 658-663.
5. Fung J, Kelly D, Kadry Z, Patel-Tom K, Eghtesad B. 2005. Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl 11: 267-280.
6. Golling M, Sadeghi M, Zipperle S, Fonouni H, Golriz M, Mehrabi A. 2009. In vitro cytokine responses in liver transplant recipients treated with cyclosporine A and tacrolimus. Clin Transplant 23( Suppl): 83-91.
7. Hall BM, Tran G, Hodgkinson SJ. 2009. Alloantigen specific T regulatory cells in transplant tolerance. Int Immunopharmacol 9: 570-574.
8. Halloran PF. 2005. Immunosuppressive drugs for kidney transplantation. N Engl J Med 351: 2715-2729.
9. Hase T, Chargui J, Inori F, Yoshimura R, Sembeil R, Nakatani T, Touraine JL. 2005. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts. Transplant Proc 37: 287-288.
10. Heo SK, Yun HJ, Park WH, Park SD. 2008. Emodin inhibits TNF-alpha-induced human aortic smooth-muscle cell proliferation via caspase- and mitochondrial- dependent apoptosis. J Cell Biochem 105: 70-80.
11. Illigens BM, Yamada A, Anosova N, Dong VM, Sayegh MH, Benichou G. 2009. Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants. Eur J Immunol 39: 3000-3009.
12. Ishizaki Y, Kawasaki S. 2007. Current status of liver transplantation and problem with hepatitis virus carriers. Nippon Naika Gakkai Zasshi 97: 99-107.
13. Jing H, Lin SZ, Yang X. 2008. Synergistic effect of emodin and cyclosporine A on rejective reaction against liver graft in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 28: 614-616.
14. Karczewski J, Karczewski M, Glyda M, Wiktorowicz K. 2008. Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc 40: 3390-3392.
15. Kobayashi E, Kamada N, Goto S, Miyata M. 1993. Protocol for the technique of orthotopic liver transplantation in the rat. Microsurgery 14: 541-546.
16. Kolarski V, Todorov A, Petrova D. 2000. Cytokines and the liver in health and disease. Vutr Boles 32: 19-24.
17. Kuo YC, Meng HC, Tsai WJ. 2001. Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflamm Res 50: 73-82.
18. Li Y, Chu N, Rostami A, Zhang GX. 2006. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177: 1679-1688.
19. Lienenlüke B, Germann T, Kroczek RA, Hecker M. 2000. CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 30: 2864-2870.
20. Lin SY, Lai WW, Ho CC, Yu FS, Chen GW, Yang JS, Liu KC, Lin ML, Wu PP, Fan MJ, Chung JG. 2009. Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res 29: 327-335.
21. Liu YX, Shen NY, Liu C, Lv Y. 2009. Immunosuppressive effects of emodin: an in vivo and in vitro study. Transplant Proc 41: 1837-1839.
22. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. 2004. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383.
23. Sayegh MH, Carpenter CB. 2004. Transplantation 50 years later: progress, challenges, and promises. N Engl J Med 351: 2761-2766.
24. Sun Y. 2008. Chemosensitization by emodin, a plant-derived anti-cancer agent: mechanism of action. Cancer Biol Ther 7: 476-478.
25. Tay SS, Plain KM, Bishop GA. 2009. Role of IL-4 and Th2 responses in allograft rejection and tolerance. Curr Opin Organ Transplant 14: 16-22.
26. Tsuchimoto S, Kusumoto K, Nakajima Y, Kakita A, Uchino J, Natori T, Aizawa M. 1988. Orthotopic liver transplantation in the rat. A simplified technique using the cuff method for suprahepatic vena cava anastomosis. Transplantation 45: 1153-1156.
27. Viveros-Paredes JM, Puebla-Pérez AM, Gutiérrez-Coronado O, Sandoval-Ramírez L, Villaseñor-García MM. 2006. Dysregulation of the Th1/Th2 cytokine profile is associated with immunosuppression induced by hypothalamic-pituitary-adrenal axis activation in mice. Int Immunopharmacol 6: 774-781.
28. Wadia PP, Tambur AR. 2008. Yin and yang of cytokine regulation in solid organ graft rejection and tolerance. Clin Lab Med 28: 469-479.
29. Zhao XY, Qiao GF, Li BX, Li BX, Chai LM, Li Z, Lu YJ, Yang BF. 2009. Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-type calcium channels in dyslipidaemic-diabetic rats. Clin Exp Pharmacol Physiol 36: 29-34.